We invite you to attend our webinar on the clinical literature evaluation process for China.
Learn More Here
Desalination: Achieving Cost-Effectiveness
By Skye McClain, Ph.D.
Originally published August 15, 2016
This article reviews the latest advances in desalination technologies.
Read More
Float like a butterfly, sting like a bee: Strategic options in an uncertain world
By Rosemary Szostak, Ph.D.
Originally published August 15, 2016
This article gives insight into the “crystal ball” of organizing for successful innovation.
Read More
Understanding CFDA Expectations Regarding Clinical Literature Evaluation for Medical Devices under Order 650: A Nerac Perspective Part III: The Final Clinical Literature Evaluation Report
By Richard Conforti, M.S.
Originally published August 15, 2016
This is the third article in a 3-part series on the 2014 Chinese Food and Drug Administration(CFDA), providing an update on their medical device regulations. The first article discussed which devices can be used to support your submission to the CFDA. The second article addressed the changes to selecting clinical literature. This article will describe the final clinical literature report.
Read More
Injection Molding: Know Your Resin Choices
By Richard Maldanis, Ph.D.
Originally published June 14, 2016
The worldwide injection molding plastic market is expected to blossom to a worth of about $162 billion dollars by 2020 and having a compound annual growth rate (CAGR) of 4.9% from 2015-2020. Learn more about the important role that innovations in resin selection plays in this growing market opportunity.
Read More
Understanding CFDA Expectations Regarding Clinical Literature Evaluation for Medical Devices under Order 650: A Nerac Perspective, Part II: Selecting the Best Clinical Literature
By Richard Conforti, M.A.
Originally published June 14, 2016
This is the second article on the 2014 Chinese Food and Drug Administration(CFDA), providing an update on their medical device regulations. The first article discussed which devices can be used to support your submission to the CFDA. In this article we will discuss the changes to selecting clinical literature.
Read More
Tire Weight Reduction in Passenger Cars & Light Trucks – Which Companies are Driving the Technology?
By Ben Bahavar, Ph.D.
Originally published June 14, 2016
Over the past few years there has been an increase in patent and non-patent activity concerning the development of new grades of engineering polymers as materials to replace some of the metal components in automobiles and airplanes.
Read More
Inspiring Innovation for Enterprise Excellence
By Ripi Singh, President & Founder, +4π LLC, Nerac Strategic Partner
Originally published May 17, 2016
How can you build and sustain a culture that helps capture market share, reduce development risk and cost, and makes your enterprise profitable, a culture that continuously stimulates growth?
Read More
Understanding CFDA Expectations Regarding Clinical Literature Evaluation for Medical Devices under Order 650: A Nerac Perspective
By Richard Conforti, M.S., Nerac Analyst
Originally Published: April 19, 2016
Understanding CFDA expectations …what you need to know to market your products in China.
Read More
Killing Them Softly: Making Strides in Green Pesticides for Consumer Use
By Stephenie Smulligan-Maldanis, M.S., Nerac Analyst
Originally Published: April 19, 2016
As the public continues to be torn between the risk disease biting pests pose, compared to the risk of materials used to combat pests, the need for new, alternate “green” products should continue to grow.
Read More
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 20
- Next Page »